Zandelisib Binding in a Single-Cycle Kinetics Assay
Cell-based study · biotinylated PIK3CD/PIK3R1 [1]
Zandelisib was evaluated against biotinylated PIK3CD/PIK3R1 using a single-cycle kinetics assay. The reported equilibrium dissociation constant for ME-401 was 30 pM.
| Endpoint | Reported result | Reference |
|---|---|---|
| equilibrium dissociation constant | KD KD of 3.03 × 10−11 M | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 1–100 nM
- Exposure duration
- a contact time of 100 s, and a flow rate of 30 µL/min. The dissociation period was 1200 s.
- Method
- Single-cycle kinetics assay
- Vehicle
- Biacore buffer containing 1% DMSO
Methods and source locations
Compound reported in the paper: Zandelisib; Compound label in the paper: ME-401
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > In Vitro Blood to Plasma Ratio, Permeability, and Binding Kinetics > Purified Enzyme-Binding Kinetics (S35, S42, S43, S44, S46, S52); Results > In Vitro Blood to Plasma Ratio, Permeability, and Binding Kinetics > Equilibrium Dissociation Constant (KD) and On/Off Rates (S102); Table 2 legend (S121)
equilibrium dissociation constant: equilibrium dissociation constant; comparator: buffer injections — Results > In Vitro Blood to Plasma Ratio, Permeability, and Binding Kinetics > Equilibrium Dissociation Constant (KD) and On/Off Rates (S102); Table 2 legend (S121)